Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
43.73
-0.12 (-0.27%)
At close: Aug 13, 2025, 4:00 PM
43.59
-0.14 (-0.32%)
Pre-market: Aug 14, 2025, 9:07 AM EDT
Artivion Market Cap
Artivion has a market cap or net worth of $2.06 billion as of August 14, 2025. Its market cap has increased by 79.91% in one year.
Market Cap
2.06B
Enterprise Value
2.27B
1-Year Change
79.91%
Ranking
Category
Stock Price
$43.73
Market Cap Chart
Since December 1, 1998, Artivion's market cap has increased from $143.30M to $2.06B, an increase of 1,339.88%. That is a compound annual growth rate of 10.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 2.07B | 72.63% |
| Dec 31, 2024 | 1.20B | 63.31% |
| Dec 29, 2023 | 733.90M | 50.14% |
| Dec 30, 2022 | 488.80M | -38.93% |
| Dec 31, 2021 | 800.40M | -12.75% |
| Dec 31, 2020 | 917.40M | -9.70% |
| Dec 31, 2019 | 1.02B | -3.16% |
| Dec 31, 2018 | 1.05B | 63.74% |
| Dec 29, 2017 | 640.70M | 1.86% |
| Dec 30, 2016 | 629.00M | 105.09% |
| Dec 31, 2015 | 306.70M | -3.13% |
| Dec 31, 2014 | 316.60M | 3.40% |
| Dec 31, 2013 | 306.20M | 79.06% |
| Dec 31, 2012 | 171.00M | 26.57% |
| Dec 30, 2011 | 135.10M | -11.41% |
| Dec 31, 2010 | 152.50M | -16.53% |
| Dec 31, 2009 | 182.70M | -33.13% |
| Dec 31, 2008 | 273.20M | 24.81% |
| Dec 31, 2007 | 218.90M | 14.91% |
| Dec 29, 2006 | 190.50M | 135.77% |
| Dec 30, 2005 | 80.80M | -51.03% |
| Dec 31, 2004 | 165.00M | 44.74% |
| Dec 31, 2003 | 114.00M | -14.73% |
| Dec 31, 2002 | 133.70M | -76.39% |
| Dec 31, 2001 | 566.30M | 0.23% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 589.23B |
| Johnson & Johnson | 418.33B |
| AbbVie | 354.35B |
| UnitedHealth Group | 244.31B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 224.15B |
| Novo Nordisk | 223.00B |